Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016 (2016), Article ID 5961342, 18 pages
http://dx.doi.org/10.1155/2016/5961342
Review Article

Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide?

1Division de Physiopathologie Clinique, Centre Hospitalier Universitaire Vaudois and University of Lausanne, 1005 Lausanne, Switzerland
2Service de Médecine Intensive Adulte, Centre Hospitalier Universitaire Vaudois and University of Lausanne, 1005 Lausanne, Switzerland

Received 18 June 2015; Revised 8 September 2015; Accepted 8 October 2015

Academic Editor: Kequan Guo

Copyright © 2016 Nathalie Rosenblatt-Velin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Kelishadi and P. Poursafa, “A review on the genetic, environmental, and lifestyle aspects of the early-life origins of cardiovascular disease,” Current Problems in Pediatric and Adolescent Health Care, vol. 44, no. 3, pp. 54–72, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. N. D. Wong, “Epidemiological studies of CHD and the evolution of preventive cardiology,” Nature Reviews Cardiology, vol. 11, no. 5, pp. 276–289, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. J. J. V. McMurray, S. Adamopoulos, S. D. Anker et al., “ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC,” European heart journal, vol. 33, no. 14, pp. 1787–1847, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Ausoni and S. Sartore, “From fish to amphibians to mammals: in search of novel strategies to optimize cardiac regeneration,” Journal of Cell Biology, vol. 184, no. 3, pp. 357–364, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Ausoni and S. Sartore, “The cardiovascular unit as a dynamic player in disease and regeneration,” Trends in Molecular Medicine, vol. 15, no. 12, pp. 543–552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. O. Bergmann, R. D. Bhardwaj, S. Bernard et al., “Evidence for cardiomyocyte renewal in humans,” Science, vol. 324, no. 5923, pp. 98–102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Kajstura, N. Gurusamy, B. Ogórek et al., “Myocyte turnover in the aging human heart,” Circulation Research, vol. 107, no. 11, pp. 1374–1386, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. P. C. H. Hsieh, V. F. M. Segers, M. E. Davis et al., “Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury,” Nature Medicine, vol. 13, no. 8, pp. 970–974, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Leri, M. Rota, F. S. Pasqualini, P. Goichberg, and P. Anversa, “Origin of cardiomyocytes in the adult heart,” Circulation Research, vol. 116, no. 1, pp. 150–166, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Laflamme and C. E. Murry, “Heart regeneration,” Nature, vol. 473, no. 7347, pp. 326–335, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. E. R. Porrello, A. I. Mahmoud, E. Simpson et al., “Transient regenerative potential of the neonatal mouse heart,” Science, vol. 331, no. 6020, pp. 1078–1080, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. S. E. Senyo, M. L. Steinhauser, C. L. Pizzimenti et al., “Mammalian heart renewal by pre-existing cardiomyocytes,” Nature, vol. 493, no. 7432, pp. 433–436, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. S. R. Ali, S. Hippenmeyer, L. V. Saadat, L. Luo, I. L. Weissman, and R. Ardehali, “Existing cardiomyocytes generate cardiomyocytes at a low rate after birth in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 24, pp. 8850–8855, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Jopling, E. Sleep, M. Raya, M. Martí, A. Raya, and J. C. Izpisua Belmonte, “Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation,” Nature, vol. 464, no. 7288, pp. 606–609, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Zhang, T.-S. Li, S.-T. Lee et al., “Dedifferentiation and proliferation of mammalian cardiomyocytes,” PLoS ONE, vol. 5, no. 9, Article ID e12559, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. G. D. Dispersyn, L. Mesotten, B. Meuris et al., “Dissociation of cardiomyocyte apoptosis and dedifferentiation in infarct border zones,” European Heart Journal, vol. 23, no. 11, pp. 849–857, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. R. B. Driesen, F. K. Verheyen, W. Debie et al., “Re-expression of alpha skeletal actin as a marker for dedifferentiation in cardiac pathologies,” Journal of Cellular and Molecular Medicine, vol. 13, no. 5, pp. 896–908, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Kubin, J. Pöling, S. Kostin et al., “Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling,” Cell Stem Cell, vol. 9, no. 5, pp. 420–432, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Rücker-Martin, F. Pecker, D. Godreau, and S. N. Hatem, “Dedifferentiation of atrial myocytes during atrial fibrillation: role of fibroblast proliferation in vitro,” Cardiovascular Research, vol. 55, no. 1, pp. 38–52, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Pöling, P. Gajawada, H. Lörchner et al., “The Janus face of OSM-mediated cardiomyocyte dedifferentiation during cardiac repair and disease,” Cell Cycle, vol. 11, no. 3, pp. 439–445, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Bersell, S. Arab, B. Haring, and B. Kühn, “Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury,” Cell, vol. 138, no. 2, pp. 257–270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Braun and S. Dimmeler, “Breaking the silence: stimulating proliferation of adult cardiomyocytes,” Developmental Cell, vol. 17, no. 2, pp. 151–153, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. G. D’Uva, A. Aharonov, M. Lauriola et al., “ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation,” Nature Cell Biology, vol. 17, no. 5, pp. 627–638, 2015. View at Publisher · View at Google Scholar
  24. C. E. Rupert and K. L. Coulombe, “The roles of neuregulin-1 in cardiac development, homeostasis, and disease,” Biomarker Insights, vol. 10, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  25. B. Kühn, F. del Monte, R. J. Hajjar et al., “Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair,” Nature Medicine, vol. 13, no. 8, pp. 962–969, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. F. R. Formiga, B. Pelacho, E. Garbayo et al., “Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration,” Journal of Controlled Release, vol. 173, no. 1, pp. 132–139, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Novoyatleva, A. Sajjad, D. Pogoryelov, C. Patra, R. T. Schermuly, and F. B. Engel, “FGF1-mediated cardiomyocyte cell cycle reentry depends on the interaction of FGFR-1 and Fn14,” FASEB Journal, vol. 28, no. 6, pp. 2492–2503, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. C. J. Hou, Y. M. Qi, D. Z. Zhang et al., “The proliferative and migratory effects of physical injury and stromal cell-derived factor-1α on rat cardiomyocytes and fibroblasts,” European Review for Medical and Pharmacological Sciences, vol. 19, no. 7, pp. 1252–1257, 2015. View at Google Scholar
  29. A. Eulalio, M. Mano, M. Dal Ferro et al., “Functional screening identifies miRNAs inducing cardiac regeneration,” Nature, vol. 492, no. 7429, pp. 376–381, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Kimura, F. Xiao, D. C. Canseco et al., “Hypoxia fate mapping identifies cycling cardiomyocytes in the adult heart,” Nature, vol. 523, no. 7559, pp. 226–230, 2015. View at Publisher · View at Google Scholar
  31. B. N. Puente, W. Kimura, S. A. Muralidhar et al., “The oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage response,” Cell, vol. 157, no. 3, pp. 565–579, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. H. M. Kaija, T. Särkioja, M.-L. Kortelainen, J. T. Vuoristo, H. V. Huikuri, and K. S. Porvari, “Stress-specific responses of p21 expression: implication of transcript variant p21 alt-a in long-term hypoxia,” Journal of Cellular Biochemistry, vol. 113, no. 2, pp. 544–552, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. A. I. Mahmoud, F. Kocabas, S. A. Muralidhar et al., “Meis1 regulates postnatal cardiomyocyte cell cycle arrest,” Nature, vol. 497, no. 7448, pp. 249–253, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. D. C. Canseco, W. Kimura, S. Garg et al., “Human ventricular unloading induces cardiomyocyte proliferation,” Journal of the American College of Cardiology, vol. 65, no. 9, pp. 892–900, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. K.-L. Laugwitz, A. Moretti, L. Caron, A. Nakano, and K. R. Chien, “Islet1 cardiovascular progenitors: a single source for heart lineages?” Development, vol. 135, no. 2, pp. 193–205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Brade, L. S. Pane, A. Moretti, K. R. Chien, and K.-L. Laugwitz, “Embryonic heart progenitors and cardiogenesis,” Cold Spring Harbor Perspectives in Medicine, vol. 3, no. 10, Article ID a013847, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Ferreira-Martins, B. Ogórek, D. Cappetta et al., “Cardiomyogenesis in the developing heart is regulated by c-kit-positive cardiac stem cells,” Circulation Research, vol. 110, no. 5, pp. 701–715, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. G. M. Ellison, C. Vicinanza, A. J. Smith et al., “Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair,” Cell, vol. 154, no. 4, pp. 827–842, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. F. Sanada, J. Kim, A. Czarna et al., “c-Kit-positive cardiac stem cells nested in hypoxic niches are activated by stem cell factor reversing the aging myopathy,” Circulation Research, vol. 114, no. 1, pp. 41–55, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. S. J. Kattman, T. L. Huber, and G. M. Keller, “Multipotent Flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages,” Developmental Cell, vol. 11, no. 5, pp. 723–732, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. V. Di Felice and G. Zummo, “Stem cell populations in the heart and the role of Isl1 positive cells,” European Journal of Histochemistry, vol. 57, article e14, 2013. View at Google Scholar · View at Scopus
  42. L. Bu, X. Jiang, S. Martin-Puig et al., “Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages,” Nature, vol. 460, no. 7251, pp. 113–117, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Hidaka, J.-K. Lee, H. S. Kim et al., “Chamber-specific differentiation of Nkx2.5-positive cardiac precursor cells from murine embryonic stem cells,” The FASEB Journal, vol. 17, no. 6, pp. 740–742, 2003. View at Google Scholar · View at Scopus
  44. A. Armiñán, C. Gandía, M. Bartual et al., “Cardiac differentiation is driven by NKX2.5 and GATA4 nuclear translocation in tissue-specific mesenchymal stem cells,” Stem Cells and Development, vol. 18, no. 6, pp. 907–918, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Takamiya, K. H. Haider, and M. Ashraf, “Identification and characterization of a novel multipotent sub-population of Sca-1(+) cardiac progenitor cells for myocardial regeneration,” PLoS ONE, vol. 6, no. 9, Article ID e25265, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Moretti, M. Bellin, C. B. Jung et al., “Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors,” The FASEB Journal, vol. 24, no. 3, pp. 700–711, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. T. I. Fuentes, N. Appleby, E. Tsay et al., “Human neonatal cardiovascular progenitors: unlocking the secret to regenerative ability,” PLoS ONE, vol. 8, no. 10, Article ID e77464, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Jain, D. Li, M. Gupta et al., “Integration of BMP and WNT signaling by Hopx specifies commitment of cardiomyoblasts,” Science, vol. 348, no. 6242, Article ID aaa6071, 2015. View at Publisher · View at Google Scholar
  49. N. Rosenblatt-Velin, M. G. Lepore, C. Cartoni, F. Beermann, and T. Pedrazzini, “FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes,” Journal of Clinical Investigation, vol. 115, no. 7, pp. 1724–1733, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. N. Smart, S. Bollini, K. N. Dubé et al., “De novo cardiomyocytes from within the activated adult heart after injury,” Nature, vol. 474, no. 7353, pp. 640–644, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. Y.-C. Hsueh, J. M. F. Wu, C.-K. Yu, K. K. Wu, and P. C. H. Hsieh, “Prostaglandin E2 promotes post-infarction cardiomyocyte replenishment by endogenous stem cells,” EMBO Molecular Medicine, vol. 6, no. 4, pp. 496–503, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. F. L. Xiang, Y. Liu, X. Lu, D. L. Jones, and Q. Feng, “Cardiac-specific overexpression of human stem cell factor promotes epicardial activation and arteriogenesis after myocardial infarction,” Circulation: Heart Failure, vol. 7, no. 5, pp. 831–842, 2014. View at Publisher · View at Google Scholar
  53. K. Malliaras, A. Ibrahim, E. Tseliou et al., “Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction,” EMBO Molecular Medicine, vol. 6, no. 6, pp. 760–777, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. V. F. M. Segers, T. Tokunou, L. J. Higgins, C. MacGillivray, J. Gannon, and R. T. Lee, “Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction,” Circulation, vol. 116, no. 15, pp. 1683–1692, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Wang, X. Zhao, C. Kuang et al., “Overexpression of SDF-1α enhanced migration and engraftment of cardiac stem cells and reduced infarcted size via CXCR4/PI3K pathway,” PLoS ONE, vol. 7, no. 9, Article ID e43922, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Nahrendorf, F. K. Swirski, E. Aikawa et al., “The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions,” The Journal of Experimental Medicine, vol. 204, no. 12, pp. 3037–3047, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. M. P. Santini and N. Rosenthal, “Myocardial regenerative properties of macrophage populations and stem cells,” Journal of Cardiovascular Translational Research, vol. 5, no. 5, pp. 700–712, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Ben-Mordechai, R. Holbova, N. Landa-Rouben et al., “Macrophage subpopulations are essential for infarct repair with and without stem cell therapy,” Journal of the American College of Cardiology, vol. 62, no. 20, pp. 1890–1901, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. F. K. Swirski, M. Nahrendorf, M. Etzrodt et al., “Identification of splenic reservoir monocytes and their deployment to inflammatory sites,” Science, vol. 325, no. 5940, pp. 612–616, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. M. Klyachkin, A. V. Karapetyan, M. Z. Ratajczak, and A. Abdel-Latif, “The role of bioactive lipids in stem cell mobilization and homing: novel therapeutics for myocardial ischemia,” BioMed Research International, vol. 2014, Article ID 653543, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Kajstura, M. Rota, B. Whang et al., “Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion,” Circulation Research, vol. 96, no. 1, pp. 127–137, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. D. Orlic, “Adult bone marrow stem cells regenerate myocardium in ischemic heart disease,” Annals of the New York Academy of Sciences, vol. 996, pp. 152–157, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Badorff, R. P. Brandes, R. Popp et al., “Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes,” Circulation, vol. 107, no. 7, pp. 1024–1032, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. N. Terada, T. Hamazaki, M. Oka et al., “Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion,” Nature, vol. 416, no. 6880, pp. 542–545, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. D. Orlic, J. Kajstura, S. Chimenti et al., “Mobilized bone marrow cells repair the infarcted heart, improving function and survival,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 18, pp. 10344–10349, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. C. E. Murry, M. H. Soonpaa, H. Reinecke et al., “Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts,” Nature, vol. 428, no. 6983, pp. 664–668, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. J. M. Nygren, S. Jovinge, M. Breitbach et al., “Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation,” Nature Medicine, vol. 10, no. 5, pp. 494–501, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Rota, J. Kajstura, T. Hosoda et al., “Bone marrow cells adopt the cardiomyogenic fate in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 45, pp. 17783–17788, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. J. Yoon, S.-C. Choi, C.-Y. Park et al., “Bone marrow-derived side population cells are capable of functional cardiomyogenic differentiation,” Molecules and Cells, vol. 25, no. 2, pp. 216–223, 2008. View at Google Scholar · View at Scopus
  70. H. Kodama, T. Inoue, R. Watanabe et al., “Cardiomyogenic potential of mesenchymal progenitors derived from human circulating CD14+ monocytes,” Stem Cells and Development, vol. 14, no. 6, pp. 676–686, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. F. S. Loffredo, M. L. Steinhauser, J. Gannon, and R. T. Lee, “Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair,” Cell Stem Cell, vol. 8, no. 4, pp. 389–398, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. P. Menasché, V. Vanneaux, J. R. Fabreguettes et al., “Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience,” European Heart Journal, vol. 36, no. 12, pp. 743–750, 2014. View at Publisher · View at Google Scholar
  73. J. J. H. Chong, X. Yang, C. W. Don et al., “Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts,” Nature, vol. 510, no. 7504, pp. 273–277, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Malecki, E. Putzer, C. Sabo et al., “Directed cardiomyogenesis of autologous human induced pluripotent stem cells recruited to infarcted myocardium with bioengineered antibodies,” Molecular and Cellular Therapies, vol. 2, article 13, 2014. View at Publisher · View at Google Scholar
  75. Z. Ding, S. Burghoff, A. Buchheiser, G. Kögler, and J. Schrader, “Survival, integration, and differentiation of unrestricted somatic stem cells in the heart,” Cell Transplantation, vol. 22, no. 1, pp. 15–27, 2013. View at Publisher · View at Google Scholar
  76. P. Menasche, “Cardiac cell therapy: lessons from clinical trials,” Journal of Molecular and Cellular Cardiology, vol. 50, no. 2, pp. 258–265, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. P. P. Young and R. Schäfer, “Cell-based therapies for cardiac disease: a cellular therapist's perspective,” Transfusion, vol. 55, no. 2, pp. 441–451, 2015. View at Publisher · View at Google Scholar · View at Scopus
  78. E. Martin-Rendon, S. Brunskill, C. Dorée et al., “Stem cell treatment for acute myocardial infarction,” Cochrane Database of Systematic Reviews, vol. 4, Article ID CD006536, 2008. View at Google Scholar · View at Scopus
  79. V. Schächinger, S. Erbs, A. Elsässer et al., “Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction,” The New England Journal of Medicine, vol. 355, no. 12, pp. 1210–1221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. G. P. Meyer, K. C. Wollert, J. Lotz et al., “Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial,” European Heart Journal, vol. 30, no. 24, pp. 2978–2984, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Gyöngyösi, W. Wojakowski, P. Lemarchand et al., “Meta-analysis of cell-based cardiac studies (ACCRUE) in patients with acute myocardial infarction based on individual patient data,” Circulation Research, vol. 116, no. 8, pp. 1346–1360, 2015. View at Publisher · View at Google Scholar
  82. S. Golpanian, J. El-Khorazaty, A. Mendizabal et al., “Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients,” Journal of the American College of Cardiology, vol. 65, no. 2, pp. 125–132, 2015. View at Publisher · View at Google Scholar · View at Scopus
  83. B. A. Nasseri, W. Ebell, M. Dandel et al., “Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial,” European Heart Journal, vol. 35, no. 19, pp. 1263–1274, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. J. M. Hare, J. H. Traverse, T. D. Henry et al., “A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction,” Journal of the American College of Cardiology, vol. 54, no. 24, pp. 2277–2286, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. R. C. Schutt, B. H. Trachtenberg, J. P. Cooke et al., “Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial,” Circulation Research, vol. 116, no. 1, pp. 99–107, 2015. View at Publisher · View at Google Scholar · View at Scopus
  86. P. Menasché, O. Alfieri, S. Janssens et al., “The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation,” Circulation, vol. 117, no. 9, pp. 1189–1200, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. J. H. Houtgraaf, W. K. den Dekker, B. M. van Dalen et al., “First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction,” Journal of the American College of Cardiology, vol. 59, no. 5, pp. 539–540, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. E. C. Perin, R. Sanz-Ruiz, P. L. Sánchez et al., “Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: the PRECISE Trial,” American Heart Journal, vol. 168, no. 1, pp. 88–95.e2, 2014. View at Publisher · View at Google Scholar · View at Scopus
  89. R. Bolli, A. R. Chugh, D. D'Amario et al., “Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial,” The Lancet, vol. 378, no. 9806, pp. 1847–1857, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. R. R. Makkar, R. R. Smith, K. Cheng et al., “Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial,” The Lancet, vol. 379, no. 9819, pp. 895–904, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. The Lancet Editors, “Expression of concern: the SCIPIO trial,” The Lancet, vol. 383, no. 9925, p. 1279, 2014. View at Publisher · View at Google Scholar · View at Scopus
  92. K. Malliaras, R. R. Makkar, R. R. Smith et al., “Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (cardiosphere-derived autologous stem cells to reverse ventricular dysfunction),” Journal of the American College of Cardiology, vol. 63, no. 2, pp. 110–122, 2014. View at Publisher · View at Google Scholar · View at Scopus
  93. N. Haque, N. H. Abu Kasim, and M. T. Rahman, “Optimization of pre-transplantation conditions to enhance the efficacy of mesenchymal stem cells,” International Journal of Biological Sciences, vol. 11, no. 3, pp. 324–334, 2015. View at Publisher · View at Google Scholar · View at Scopus
  94. J. M. Polo, S. Liu, M. E. Figueroa et al., “Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells,” Nature Biotechnology, vol. 28, no. 8, pp. 848–855, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. G. Liang and Y. Zhang, “Genetic and epigenetic variations in iPSCs: potential causes and implications for application,” Cell Stem Cell, vol. 13, no. 2, pp. 149–159, 2013. View at Publisher · View at Google Scholar · View at Scopus
  96. M. Hofmann, K. C. Wollert, G. P. Meyer et al., “Monitoring of bone marrow cell homing into the infarcted human myocardium,” Circulation, vol. 111, no. 17, pp. 2198–2202, 2005. View at Publisher · View at Google Scholar · View at Scopus
  97. M. Z. Ratajczak, M. Kucia, T. Jadczyk et al., “Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies,” Leukemia, vol. 26, no. 6, pp. 1166–1173, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. G. Maguire, “Stem cell therapy without the cells,” Communicative & Integrative Biology, vol. 6, no. 6, Article ID e26631, 2013. View at Publisher · View at Google Scholar · View at Scopus
  99. S. M. Chacko, M. Khan, M. L. Kuppusamy et al., “Myocardial oxygenation and functional recovery in infarct rat hearts transplanted with mesenchymal stem cells,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 296, no. 5, pp. H1263–H1273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. Y. Imanishi, A. Saito, H. Komoda et al., “Allogenic mesenchymal stem cell transplantation has a therapeutic effect in acute myocardial infarction in rats,” Journal of Molecular and Cellular Cardiology, vol. 44, no. 4, pp. 662–671, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. D. C. Vela, G. V. Silva, J. A. R. Assad et al., “Histopathological study of healing after allogenic mesenchymal stem cell delivery in myocardial infarction in dogs,” Journal of Histochemistry and Cytochemistry, vol. 57, no. 2, pp. 167–176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  102. R. R. Makkar, M. J. Price, M. Lill et al., “Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 10, no. 4, pp. 225–233, 2005. View at Publisher · View at Google Scholar · View at Scopus
  103. L. V. Kursova, A. G. Konoplyannikov, S. S. Kal'sina, and S. B. Baboyan, “Allogenic cardiomyoblasts raised from human mesenchymal stem cells in the therapy of radiation cardiomyopathy and pericarditis: case report,” Bulletin of Experimental Biology and Medicine, vol. 157, no. 1, pp. 143–145, 2014. View at Publisher · View at Google Scholar · View at Scopus
  104. R. R. U. Smith, E. Marban, and L. Marban, “Enhancing retention and efficacy of cardiosphere-derived cells administered after myocardial infarction using a hyaluronan-gelatin hydrogel,” Biomatter, vol. 3, no. 1, Article ID e24490, 2013. View at Publisher · View at Google Scholar · View at Scopus
  105. K. Malliaras, T.-S. Li, D. Luthringer et al., “Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells,” Circulation, vol. 125, no. 1, pp. 100–112, 2012. View at Publisher · View at Google Scholar · View at Scopus
  106. M. Drukker, H. Katchman, G. Katz et al., “Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells,” Stem Cells, vol. 24, no. 2, pp. 221–229, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. M. Drukker, G. Katz, A. Urbach et al., “Characterization of the expression of MHC proteins in human embryonic stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 15, pp. 9864–9869, 2002. View at Publisher · View at Google Scholar · View at Scopus
  108. C. Bocelli-Tyndall, E. Trella, A. Frachet et al., “FGF2 induces RANKL gene expression as well as IL1β regulated MHC class II in human bone marrow-derived mesenchymal progenitor stromal cells,” Annals of the Rheumatic Diseases, vol. 74, no. 1, pp. 260–266, 2015. View at Publisher · View at Google Scholar · View at Scopus
  109. C. Bocelli-Tyndall, P. Zajac, N. Di Maggio et al., “Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells,” Arthritis and Rheumatism, vol. 62, no. 12, pp. 3815–3825, 2010. View at Publisher · View at Google Scholar · View at Scopus
  110. P. Lohan, C. M. Coleman, J. M. Murphy, M. D. Griffin, T. Ritter, and A. E. Ryan, “Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?” Stem Cell Research & Therapy, vol. 5, article 99, 2014. View at Publisher · View at Google Scholar · View at Scopus
  111. J. L. Zakrzewski, M. R. M. van den Brink, and J. A. Hubbell, “Overcoming immunological barriers in regenerative medicine,” Nature Biotechnology, vol. 32, no. 8, pp. 786–794, 2014. View at Publisher · View at Google Scholar · View at Scopus
  112. R. Al-Daccak and D. Charron, “Allogenic benefit in stem cell therapy: cardiac repair and regeneration,” Tissue Antigens, vol. 86, no. 3, pp. 155–162, 2015. View at Publisher · View at Google Scholar
  113. B. Zhou, Q. Ma, S. Rajagopal et al., “Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart,” Nature, vol. 454, no. 7200, pp. 109–113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. A. Leri, J. Kajstura, and P. Anversa, “Cardiac stem cells and mechanisms of myocardial regeneration,” Physiological Reviews, vol. 85, no. 4, pp. 1373–1416, 2005. View at Publisher · View at Google Scholar · View at Scopus
  115. K. Urbanek, D. Cesselli, M. Rota et al., “Stem cell niches in the adult mouse heart,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 24, pp. 9226–9231, 2006. View at Publisher · View at Google Scholar · View at Scopus
  116. F. Limana, A. Germani, A. Zacheo et al., “Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation,” Circulation research, vol. 97, no. 8, pp. e73–e83, 2005. View at Publisher · View at Google Scholar · View at Scopus
  117. C. Bielmann, S. Rignault-Clerc, L. Liaudet et al., “Brain natriuretic peptide is able to stimulate cardiac progenitor cell proliferation and differentiation in murine hearts after birth,” Basic Research in Cardiology, vol. 110, article 455, 2015. View at Publisher · View at Google Scholar
  118. V. Dayan, G. Yannarelli, F. Billia et al., “Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction,” Basic Research in Cardiology, vol. 106, no. 6, pp. 1299–1310, 2011. View at Publisher · View at Google Scholar · View at Scopus
  119. T. Nishikimi, K. Kuwahara, and K. Nakao, “Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides,” Journal of Cardiology, vol. 57, no. 2, pp. 131–140, 2011. View at Publisher · View at Google Scholar · View at Scopus
  120. L. R. Potter, A. R. Yoder, D. R. Flora, L. K. Antos, and D. M. Dickey, “Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications,” in cGMP: Generators, Effectors and Therapeutic Implications, vol. 191 of Handbook of Experimental Pharmacology, pp. 341–366, Springer, Berlin, Germany, 2009. View at Publisher · View at Google Scholar
  121. A. Clerico, S. Vittorini, and C. Passino, “Circulating forms of the b-type natriuretic peptide prohormone: pathophysiologic and clinical considerations,” Advances in Clinical Chemistry, vol. 58, pp. 31–44, 2012. View at Publisher · View at Google Scholar · View at Scopus
  122. E. Morita, H. Yasue, M. Yoshimura et al., “Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction,” Circulation, vol. 88, no. 1, pp. 82–91, 1993. View at Publisher · View at Google Scholar · View at Scopus
  123. F. Liang, J. O'Rear, U. Schellenberger et al., “Evidence for functional heterogeneity of circulating B-type natriuretic peptide,” Journal of the American College of Cardiology, vol. 49, no. 10, pp. 1071–1078, 2007. View at Publisher · View at Google Scholar · View at Scopus
  124. H. H. Chen, “Heart failure: a state of brain natriuretic peptide deficiency or resistance or both!,” Journal of the American College of Cardiology, vol. 49, no. 10, pp. 1089–1091, 2007. View at Publisher · View at Google Scholar · View at Scopus
  125. A. H. Bruggink, N. de Jonge, M. F. M. van Oosterhout et al., “Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device,” Journal of Heart and Lung Transplantation, vol. 25, no. 2, pp. 174–180, 2006. View at Publisher · View at Google Scholar · View at Scopus
  126. E. M. Abdelalim and I. Tooyama, “BNP signaling is crucial for embryonic stem cell proliferation,” PLoS ONE, vol. 4, no. 4, Article ID e5341, 2009. View at Publisher · View at Google Scholar · View at Scopus
  127. M. Kuhn, K. Völker, K. Schwarz et al., “The natriuretic peptide/guanylyl cyclase—a system functions as a stress-responsive regulator of angiogenesis in mice,” Journal of Clinical Investigation, vol. 119, no. 7, pp. 2019–2030, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. K. Kuwahara and K. Nakao, “Regulation and significance of atrial and brain natriuretic peptides as cardiac hormones,” Endocrine Journal, vol. 57, no. 7, pp. 555–565, 2010. View at Publisher · View at Google Scholar · View at Scopus
  129. S. P. D'Souza and G. F. Baxter, “B type natriuretic peptide: a good omen in myocardial ischaemia?” Heart, vol. 89, no. 7, pp. 707–709, 2003. View at Publisher · View at Google Scholar · View at Scopus
  130. B. Ren, Y. Shen, H. Shao, J. Qian, H. Wu, and H. Jing, “Brain natriuretic peptide limits myocardial infarct size dependent of nitric oxide synthase in rats,” Clinica Chimica Acta, vol. 377, no. 1-2, pp. 83–87, 2007. View at Publisher · View at Google Scholar · View at Scopus
  131. D. S. Burley and G. F. Baxter, “B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart,” Basic Research in Cardiology, vol. 102, no. 6, pp. 529–541, 2007. View at Publisher · View at Google Scholar · View at Scopus
  132. B. Wu, H. Jiang, R. Lin, B. Cui, H. Wen, and Z. Lu, “Pretreatment with B-type natriuretic peptide protects the heart from ischemia-reperfusion injury by inhibiting myocardial apoptosis,” Tohoku Journal of Experimental Medicine, vol. 219, no. 2, pp. 107–114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  133. A.-M. Moilanen, J. Rysä, E. Mustonen et al., “Intramyocardial BNP gene delivery improves cardiac function through distinct context-dependent mechanisms,” Circulation: Heart Failure, vol. 4, no. 4, pp. 483–495, 2011. View at Publisher · View at Google Scholar · View at Scopus
  134. A. Cataliotti, J. M. Tonne, D. Bellavia et al., “Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats,” Circulation, vol. 123, no. 12, pp. 1297–1305, 2011. View at Publisher · View at Google Scholar · View at Scopus
  135. N. Glezeva, P. Collier, V. Voon et al., “Attenuation of monocyte chemotaxis-a novel anti-inflammatory mechanism of action for the cardio-protective hormone B-type natriuretic peptide,” Journal of Cardiovascular Translational Research, vol. 6, no. 4, pp. 545–557, 2013. View at Publisher · View at Google Scholar · View at Scopus
  136. S. M. Shaw, J. E. Fildes, C. M. Puchałka, M. Basith, N. Yonan, and S. G. Williams, “BNP directly immunoregulates the innate immune system of cardiac transplant recipients in vitro,” Transplant Immunology, vol. 20, no. 3, pp. 199–202, 2009. View at Publisher · View at Google Scholar · View at Scopus
  137. V. Chiurchiù, V. Izzi, F. D'Aquilio, F. Carotenuto, P. Di Nardo, and P. M. Baldini, “Brain Natriuretic Peptide (BNP) regulates the production of inflammatory mediators in human THP-1 macrophages,” Regulatory Peptides, vol. 148, no. 1–3, pp. 26–32, 2008. View at Publisher · View at Google Scholar · View at Scopus
  138. R. Kawakami, Y. Saito, I. Kishimoto et al., “Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction,” Circulation, vol. 110, no. 21, pp. 3306–3312, 2004. View at Publisher · View at Google Scholar · View at Scopus
  139. B. B. Das, S. Raj, and R. Solinger, “Natriuretic peptides in cardiovascular diseases of fetus, infants and children,” Cardiovascular & Hematological Agents in Medicinal Chemistry, vol. 7, no. 1, pp. 43–51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  140. V. A. Cameron and L. J. Ellmers, “Minireview: natriuretic peptides during development of the fetal heart and circulation,” Endocrinology, vol. 144, no. 6, pp. 2191–2194, 2003. View at Publisher · View at Google Scholar · View at Scopus
  141. J. R. Becker, S. Chatterjee, T. Y. Robinson et al., “Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development,” Development, vol. 141, no. 2, pp. 335–345, 2014. View at Publisher · View at Google Scholar · View at Scopus
  142. V. A. Cameron, G. D. Aitken, L. J. Ellmers, M. A. Kennedy, and E. A. Espiner, “The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta,” Endocrinology, vol. 137, no. 3, pp. 817–824, 1996. View at Publisher · View at Google Scholar · View at Scopus
  143. L. Schwachtgen, M. Herrmann, T. Georg, P. Schwarz, N. Marx, and A. Lindinger, “Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children,” Zeitschrift für Kardiologie, vol. 94, no. 6, pp. 399–404, 2005. View at Publisher · View at Google Scholar · View at Scopus
  144. J. M. Tonne, J. M. Campbell, A. Cataliotti et al., “Secretion of glycosylated pro-B-type natriuretic peptide from normal cardiomyocytes,” Clinical Chemistry, vol. 57, no. 6, pp. 864–873, 2011. View at Publisher · View at Google Scholar · View at Scopus
  145. J. Peng, J. Jiang, W. Wang, X. Qi, X.-L. Sun, and Q. Wu, “Glycosylation and processing of pro-B-type natriuretic peptide in cardiomyocytes,” Biochemical and Biophysical Research Communications, vol. 411, no. 3, pp. 593–598, 2011. View at Publisher · View at Google Scholar · View at Scopus
  146. N. J. A. Scott, L. J. Ellmers, J. G. Lainchbury et al., “Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1792, no. 12, pp. 1175–1184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  147. E. M. Abdelalim and I. Tooyama, “NPR-A regulates self-renewal and pluripotency of embryonic stem cells,” Cell Death & Disease, vol. 2, no. 3, article e127, 2011. View at Publisher · View at Google Scholar · View at Scopus
  148. L. J. Ellmers, N. J. A. Scott, J. Piuhola et al., “Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis,” Journal of Molecular Endocrinology, vol. 38, no. 1-2, pp. 245–257, 2007. View at Publisher · View at Google Scholar · View at Scopus
  149. J. W. Knowles, G. Esposito, L. Mao et al., “Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice,” The Journal of Clinical Investigation, vol. 107, no. 8, pp. 975–984, 2001. View at Publisher · View at Google Scholar · View at Scopus
  150. I. Kishimoto, T. Tokudome, T. Horio, D. L. Garbers, K. Nakao, and K. Kangawa, “Natriuretic peptide signaling via guanylyl cyclase (GC)-A: an endogenous protective mechanism of the heart,” Current Cardiology Reviews, vol. 5, no. 1, pp. 45–51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  151. C. Sogawa, A. Abe, T. Tsuji, M. Koizumi, T. Saga, and T. Kunieda, “Gastrointestinal tract disorder in natriuretic peptide receptor B gene mutant mice,” The American Journal of Pathology, vol. 177, no. 2, pp. 822–828, 2010. View at Publisher · View at Google Scholar · View at Scopus
  152. C. Sogawa, T. Tsuji, Y. Shinkai, K. Katayama, and T. Kunieda, “Short-limbed dwarfism: slw is a new allele of Npr2 causing chondrodysplasia,” The Journal of Heredity, vol. 98, no. 6, pp. 575–580, 2007. View at Publisher · View at Google Scholar · View at Scopus
  153. N. Tamura, L. K. Doolittle, R. E. Hammer, J. M. Shelton, J. A. Richardson, and D. L. Garbers, “Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 49, pp. 17300–17305, 2004. View at Publisher · View at Google Scholar · View at Scopus
  154. C. Sogawa, Y. Fujiwara, S. Tsukamoto et al., “Mutant phenotype analysis suggests potential roles for C-type natriuretic peptide receptor (NPR-B) in male mouse fertility,” Reproductive Biology and Endocrinology, vol. 12, article 64, 2014. View at Publisher · View at Google Scholar · View at Scopus
  155. K. A. Geister, M. L. Brinkmeier, M. Hsieh et al., “A novel loss-of-function mutation in Npr2 clarifies primary role in female reproduction and reveals a potential therapy for acromesomelic dysplasia, Maroteaux type,” Human Molecular Genetics, vol. 22, no. 2, pp. 345–357, 2013. View at Publisher · View at Google Scholar · View at Scopus
  156. T. H. Langenickel, J. Buttgereit, I. Pagel-Langenickel et al., “Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 12, pp. 4735–4740, 2006. View at Publisher · View at Google Scholar · View at Scopus
  157. T. Ahmad and G. M. Felker, “Subcutaneous B-type natriuretic peptide for treatment of heart failure: a dying therapy reborn?” Journal of the American College of Cardiology, vol. 60, no. 22, pp. 2313–2315, 2012. View at Publisher · View at Google Scholar · View at Scopus
  158. C. Partovian, S.-X. Li, X. Xu et al., “Patterns of change in nesiritide use in patients with heart failure: how hospitals react to new information,” JACC: Heart Failure, vol. 1, no. 4, pp. 318–324, 2013. View at Publisher · View at Google Scholar · View at Scopus
  159. S. S. Gottlieb, A. Stebbins, A. A. Voors et al., “Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure),” Journal of the American College of Cardiology, vol. 62, no. 13, pp. 1177–1183, 2013. View at Publisher · View at Google Scholar · View at Scopus
  160. C. M. O'Connor, R. C. Starling, A. F. Hernandez et al., “Effect of nesiritide in patients with acute decompensated heart failure,” The New England Journal of Medicine, vol. 365, no. 1, pp. 32–43, 2011. View at Publisher · View at Google Scholar
  161. H. H. Chen, F. L. Martin, R. J. Gibbons et al., “Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study,” Heart, vol. 95, no. 16, pp. 1315–1319, 2009. View at Publisher · View at Google Scholar · View at Scopus
  162. H. H. Chen, J. F. Glockner, J. A. Schirger, A. Cataliotti, M. M. Redfield, and J. C. Burnett Jr., “Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptide,” Journal of the American College of Cardiology, vol. 60, no. 22, pp. 2305–2312, 2012. View at Publisher · View at Google Scholar · View at Scopus
  163. T. Lyu, Y. Zhao, T. Zhang et al., “Natriuretic peptides as an adjunctive treatment for acute myocardial infarction,” International Heart Journal, vol. 55, no. 1, pp. 8–16, 2014. View at Google Scholar
  164. S. J. Sangaralingham, J. C. Burnett Jr., P. M. McKie, J. A. Schirger, and H. H. Chen, “Rationale and design of a randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of B-type natriuretic peptide for the preservation of left ventricular function after anterior myocardial infarction,” Journal of Cardiac Failure, vol. 19, no. 8, pp. 533–539, 2013. View at Publisher · View at Google Scholar · View at Scopus
  165. J. J. V. McMurray, M. Packer, A. S. Desai et al., “Angiotensin-neprilysin inhibition versus enalapril in heart failure,” The New England Journal of Medicine, vol. 371, no. 11, pp. 993–1004, 2014. View at Publisher · View at Google Scholar · View at Scopus
  166. M. Packer, J. J. McMurray, A. S. Desai et al., “Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure,” Circulation, vol. 131, no. 1, pp. 54–61, 2015. View at Publisher · View at Google Scholar
  167. W. Jiang, D.-Y. Cai, C.-S. Pan et al., “Changes in production and metabolism of brain natriuretic peptide in rats with myocardial necrosis,” European Journal of Pharmacology, vol. 507, no. 1–3, pp. 153–162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  168. Y. Hirata, H. Hayakawa, E. Suzuki, and M. Omata, “Does endothelin work as an intrarenal mechanism to alter pressure natriuresis in spontaneously hypertensive rats?” Journal of Hypertension, vol. 12, no. 3, pp. 251–257, 1994. View at Google Scholar · View at Scopus
  169. J. Xu, O. A. Carretero, Y.-H. Liu et al., “Dual inhibition of ACE and NEP provides greater cardioprotection in mice with heart failure,” Journal of Cardiac Failure, vol. 10, no. 1, pp. 83–89, 2004. View at Publisher · View at Google Scholar · View at Scopus
  170. T. G. von Lueder, B. H. Wang, A. R. Kompa et al., “Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy,” Circulation: Heart Failure, vol. 8, no. 1, pp. 71–78, 2015. View at Publisher · View at Google Scholar
  171. A. S. Jaffe, “Unwinding the interaction of natriuretic peptides and neprilysin,” Journal of the American College of Cardiology, vol. 65, no. 7, pp. 666–667, 2015. View at Publisher · View at Google Scholar · View at Scopus
  172. J. C. Garbern and R. T. Lee, “Cardiac stem cell therapy and the promise of heart regeneration,” Cell Stem Cell, vol. 12, no. 6, pp. 689–698, 2013. View at Publisher · View at Google Scholar · View at Scopus
  173. S. A. Doppler, M.-A. Deutsch, R. Lange, and M. Krane, “Cardiac regeneration: current therapies-future concepts,” Journal of Thoracic Disease, vol. 5, no. 5, pp. 683–697, 2013. View at Publisher · View at Google Scholar · View at Scopus
  174. S.-Y. Liao and H.-F. Tse, “Multipotent (adult) and pluripotent stem cells for heart regeneration: what are the pros and cons?” Stem Cell Research & Therapy, vol. 4, article 151, 2013. View at Publisher · View at Google Scholar · View at Scopus